eli lilly sues compounders for selling unauthorized tirzepatide copies Compounding group FDA removing obesity drug from shortages list Lilly warns of 'impurity' in

In DAPA-HF, at baseline, 94% of patients were treated with ACEi, ARB or angiotensin receptor-neprilysin inhibitor (ARNI, including sacubitril/valsartan 11%), 96% with beta-blocker, 71% with mineralocorticoid receptor antagonist (MRA), 93% with diuretic, and 26% had an implantable device (with defibrillator function)

Magnesium also supports muscle relaxation and recovery

BPC-157: Commonly cited at 250 to 500 mcg once or twice daily, given subcutaneously or as a local injection

Semaglutide is a once-weekly injectable medication that helps support healthy, sustainable weight loss by naturally curbing appetite and promoting fullness

GLP-1 Receptor Activation Indirectly Reduces Hepatic Lipid Accumulation But Does Not Attenuate Development of Atherosclerosis in Diabetic Male ApoE / Mice